TipRanks
pc:cre3h

CREATE Medicines

300 Technology Sq 2nd Floor Cambridge, Massachusetts 02139, US
https://createmedicines.com/
CREATE Medicines is a biotechnology company developing in vivo CAR therapies focused on both autoimmune diseases and oncology. The company is advancing repeat-dose capable CD19-targeted in vivo CAR-T therapies and dual CAR programs such as CD19 x BCMA, leveraging its platform to enable targeted, repeat-administered cellular reprogramming.

Leadership & Board

Current Number of Employees47
Current LinkedIn Followers10,153

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$122M
Total Amount Raised$122M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$122M
Latest Funding Amount$122M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Employee Trend

CREATE Medicines had 47 employees as of September 14, 2026. The number of employees increased by 1 (2.17%) week-over-week.
47Latest Employee Count
1(2.17%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

CREATE Medicines had 10,153 followers as of September 14, 2026. The number of followers increased by 15 (0.15%) week-over-week.
10,153Latest Followers Count
15(0.15%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
May 14, 2026
Series B
$122.00M

Investors

Investor Name
Funding Round

Similar Companies

A snapshot of private companies similar to CREATE Medicines, helping you discover and navigate related company profiles.

Related News and Analysis